Kubo T, Hirohashi Y, Matsuo K, Sonoda T, Sakamoto H, Furumura K, Tsukahara T, Kanaseki T, Nakatsugawa M, Hirano H, Furuhata T, Takemasa I, Hasegawa T, Torigoe T., Mismatch Repair Protein Deficiency Is a Risk Factor for Aberrant Expression of HLA Class I Molecules: A Putative “Adaptive Immune Escape” Phenomenon., Anticancer Res., 37, 3, 1289-1295, 2017, 3
Miyo M, Takemasa I, Ikeda M, Tujie M, Hasegawa J, Ohue M, Kato T, Mizushima T, Doki Y, Mori M., The influence of specific technical maneuvers utilized in the creation of diverting loop-ileostomies on stoma-related morbidity., Surg Today, 2017, 3
Miyo M, Konno M,Colvin H,Nishida N,Koseki J,Kawamoto K, Tsunekuni K,Nishimura J,Hata T,Takemasa I,Mizushima T,Doki Y,Mori M,Ishii H, The importance of mitochondrial folate enzymes in human colorectal cancer., Oncol Rep, 37, 1, 417-425, 2017, 1
Yasui M, Ikeda M,Miyake M,Lde Y,Okuyama M,Shingai T,Kitani K,Ikenaga M,Hasegawa J,Akamatsu H,Murata K,Takemasa I,Mizushima T,Yamamoto H,Sekimoto M,Nezu R,Doki Y,Mori M;Clinical Study Group of Osaka University(CSGO),Colorectal Group, Comparison of bleeding risks related to venous thromboembolism prophylaxis in laparoscopic vs open colorectal cancer surgery: a multicenter study in Japanese patients., Am J Surg, 213, 1, 43-49, 2017, 1
Yamamoto I, Nosho K,Kanno S,Igarashi H,zkurihara H,Ishigami K,Ishiguro K,Mitsuhashi K,Maruyama R,Koide H,Okuda H,Hasegawa T,Sukawa YOkita K,Takemasa I,Yamamoto H,Shinomura Y,Nakase H, EZH2 expression is a prognostic biomarker in patients with colorectal cancer treated with anti-EGFR therapeutics., Oncotarget, 8, 11, 17810-17818, 2017, 3
Kanazaki R, Inoue M,Kimura T,Kawamura T,Funaki S,Shintani Y,Minami M,Takemasa I,Mizushima T,Mori M,Okumura M, Role of pulmonary metastasectomy in colorectal cancer in the era of modern multidisciplinary therapy., Surg Today, 2017, 2
Takemoto H, Nishimura J,Komori T,Kim HM,Ota H,Suzuki R,Ikenaga M,Ikeda M,Yamamoto H,Satoh T,Hata T,Takemasa I,Mizushima T,Doki Y,Mori M,Multicenter Clinical Study Group of Osaka,Colorectal Cancer Treatment Group, Combination antiemetic therapy with aprepitant/fosaprepitant in patients with colorectal cancer receiving oxaliplatin-based chemotherapy in the SENRI trial: analysis of risk factors for vomiting and nausea., Int J Clin Oncol, 22, 1, 88-95, 2017, 2
Hata T, Mizushima T,Osawa H,Takahashi H,Haraguchi N,Nishimura J, Hata T,Takemasa I,Ikenaga M,Nakajima K,Yamamoto H,Murata K, Doki Y,Mori M, Short-term outcomes of laparoscopic surgery for Crohn’s disease patients treated with anti-tumor necrosis factor alpha agents., Surg Today, 47, 3, 320-327, 2017, 3
Osawa H, Takahashi H, Nishimura J, Ohta K, Haraguchi N, Hata T, Yamamoto H, Mizushima T, Takemasa I, Doki Y, Mori M., Full-length LGR5-positive cells have chemoresistant characteristics in colorectal cancer., Br J Cancer, 114, 11, 1251-1260, 2016, 5
Shima H, Kutomi G, Satomi F, Maeda H, Hirohashi Y, Hasegawa T, Mori M, Torigoe T, Takemasa I., SOX2 and ALDH1 as Predictors of Operable Breast Cancer., Anticancer Res, 36, 6, 2945-2953, 2016, 6
Yamamoto H, Murata K, Fukunaga M, Ohnishi T, Noura S, Miyake Y, Kato T, Ohtsuka M, Nakamura Y, Takemasa I, Mizushima T, Ikeda M, Ohue M, Sekimoto M, Nezu R, Matsuura N, Monden M, Doki Y, Mori M., Micrometastasis Volume in Lymph Nodes Determines Disease Recurrence Rate of Stage II Colorectal Cancer: A Prospective Multicenter Trial, Clin Cancer Res, 22, 13, 3201-3208, 2016, 7
Mizushima T, Takahashi H, Takeyama H, Naito A, Haraguchi N, Uemura M, Nishimura J, Hata T, Takemasa I, Yamamoto H, Doki Y, Mori M., A clinical trial of autologous adipose-derived regenerative cell transplantation for a postoperative enterocutaneous fistula., Surg Today, 46, 7, 835-842, 2016, 7
Takaya A, Hirohashi Y,Murai A,Morita R,Saijo H,Yamamoto E,Kubo T, Nakatsugawa M,Kanaseki T,Tsukahara T,Tamura Y,Takemasa I, Kondo T,Sato N,Torigoe T, Establishment and Analysis of Cancer Stem-Like and Non-Cancer Stem-Like Clone Cells from the Human Colon Cancer Cell Line SW480., PLoS One, 11, 7, e0158903, 2016, 7
Hamabe A, Takemasa I,Hata T,Mizushima T,Doki Y,Mori M, Patient Body Image and Satisfaction with Surgical Wound Appearance After Reduced Port Surgery for Colorectal Diseases., World J Surg, 40, 7, 1748-1754, 2016, 7
Uemura M, Kim HM,Hata T,Sakata K,Okuyama M,Takemoto H,Fukuzaki T, Morita T,Hata T,Takemasa I,Satoh T,Mizushima T,Doki Y,Mori M; Multicenter Clinical Study Group of Osaka,Colorectal Cancer Treatment Group(MCSGO), First-line cetuximab-based chemotherapies for patients with advanced or metastatic KRAS wild-type colorectal cancer., Mol Clin Oncol, 5, 2, 375-379, 2016, 8
Uemura M, Kim HM,Ikeda M,Nishimura J,Hata T,Takemasa I, Mizushima T, Yamamoto H,Doki Y,Mori M, Long-term outcome of adrenalectomy for metastasis resulting from colorectal cancer with other metastatic sites: A report of 3 cases., Oncol Lett, 12, 3, 1649-1654, 2016, 9
Maeda H, Kutomi G,Satomi F,Shima H,Mori M,Hirata K,Takemasa I, Clinicopathological characteristics of thyroid cancer misdiagnosed by fine needle aspiration., Exp Ther Med, 12, 4, 2766-2772, 2016, 10
Nishimura J, Hasegawa J,Ogawa Y,Miwa H,Uemura M,Haraguchi N,Hata T, Yamamoto H,Takemasa I,Mizushima T,Nezu R,Doki Y,Mori M, (18)F-Fluorodeoxyglucose positron emission tomography ((18)F-FDG PET) for the early detection of response to neoadjuvant chemotherapy for locally advanced rectal cancer., Surg Today, 46, 10, 1152-1158, 2016, 10
Munakata K, Uemura M, Tanaka S, Kawai K, Kitahara T, Miyo M, Kano Y, Nishikawa S, Fukusumi T, Takahashi Y, Hata T, Nishimura J, Takemasa I, Mizushima T, Ikenaga M, Kato T, Murata K, Carethers JM, Yamamoto H, Doki Y, Mori M., Cancer stem-like properties in colorectal cancer cells with low proteasome activity., Clin Cancer Res, 22, 21, 5277-5286, 2016, 11
Yamamoto H, Oshiro R, Ohtsuka M,Uemura M,Haraguchi N,Nishimura J, Takemasa I, Mizushima T,Doki Y,Mori M, [Corrigendum] Distinct expression of C4.4A in colorectal cancer detected by different antibodies., Int J Oncol, 49, 5, 2186, 2016, 11
Akita H, Ritchie SA,Takemasa I,Eguchi H,Pastural E,Jin W,Yamazaki Y, Goodenowe DB,Nagano H,Monden M,Mori M,Doki Y, Serum Metabolite Profiling for the Detection of Pancreatic Cancer: Results of a Large Independent Validation Study., Pancreas, 45, 10, 1418-1423, 2016, 11
Shima H, Kutomi G, Kyuno T, Satomi F, Uno S, Maeda H, Kameshima H, Omura T, Kimura Y, Mizuguchi T, Hirata K, Takemasa I., Flap revascularization in patients following immediate reconstruction using an autologous free dermal fat graft for breast cancer: a report of two cases., Surg Case Rep, 2, 1, 54, 2016, 12
Takahashi H, Takemasa I, Haraguchi N, Nishimura J, Hata T,Yamamoto H,Matsuda C, Mizushima T, Doki Y,Mari M, The single-center experience with the standardization of single-site laparoscopic colectomy for right-sided colon cancer., Surg Today, 2016, 12
Mokutani Y, Uemura M,Munakata K,Okuzaki D,Haraguchi N,Takahashi H, Nishimura J,Hata T,Murata K,Takemasa I,Mizushima T,Doki Y, Mori M,Yamamoto H, Down-Regulation of microRNA-132 is Associated with Poor Prognosis of Colorectal Cancer., Ann Surg Oncol, 23, 5, 599-608, 2016, 12
Ichinohe N, Ishii M, Tanimizu N, Kon J, Yoshioka Y, Ochiya T, Mizuguchi T, Hirata K, Mitaka T. , Transplantation of Thy1+ Cells Accelerates Liver Regeneration by Enhancing the Growth of Small Hepatocyte-like Progenitor Cells via IL17RB Signaling. , Stem Cells., 34, 12, 920-931, 2017
Tanimizu N, Ichinohe N, Ishii M, Kino J, Mizuguchi T, Hirata K, Mitaka T, Liver progenitors isolated from adult healthy mouse liver efficiently differentiate to functional hepatocytes in vitro and repopulate liver tissue., Stem Cells., 34, 12, 2889-2901, 2016
Tanimizu N, Kaneko K, Itoh T, Ichinohe N, Ishii M, Mizuguchi T, Hirata K, Miyajima A, Mitaka T., Intrahepatic bile ducts are developed through formation of homogeneous continuous luminal network and its dynamic rearrangement., Hepatology., 64, 1, 175-88, 2016
Kinoshita M, Kubo S, Nakanuma Y, Sato Y, Takemura S, Tanaka S, Hamano G, Ito T, Terajima H, Yamada T, Nakamori S, Arimoto A, Fujikawa M, Sugawara Y, Yamamoto T, Abue M, Nakagawa K, Unno M, Mizuguchi T, Takenaka K, Shirabe K, and Shibata T:, Pathological spectrum of bile duct lesions from chronic bile duct injury to invasive cholangiocarcinoma corresponding to bile duct imaging findings of occupational cholangiocarcinoma., J Hepatobiliary Pancreat Sci., 23, 92-101, 2016
Nagayama M, Mizuguchi T, Yamaguchi H, Imamura M, Kutomi G, Okita K, Nishidate T, Takemasa I, Kimura Y., Technical aspects and surgical complications of laparoscopic liver resection. , Ann Laparosc Endosc Surg, 2, 61, 2017
Nakao H, Wakai K, Ishii N, Kobayashi Y, Ito K, Yoneda M, Mori M, Nojima M, Kimura Y, Endo T, Matsuyama M, Ishii H, Ueno M, Kuruma S, Egawa N, Matsuo K, Hosono S, Ohkawa S, Nakamura K, Tamakoshi A, Takahashi M, Shimada K, Nishiyama T, Kikuchi S, Lin Y, Associations between polymorphisms in folate-metabolizing genes and pancreatic cancer risk in Japanese subjects:, BMC Gastroenterology, 16, 1, 2016, doi: 10.1186/s12876-016-0503-7.
Shima H, Kutomi G, Kyuno T, Satomi F, Uno S, Maeda H, Kameshima H, Omura T, Kimura Y, Mizuguchi T, Hirata K, Takemasa I., Flap revascularization in patients following immediate reconstruction using an autologous free dermal fat graft for breast cancer: a report of two cases., Surg Case Rep, 2, 1, 54, 2016, doi: 10.1186/s40792-016-0181-2. Epub 2016 Jun 3.
Kutomi G, Mizuguchi T, Satomi F, Maeda H, Shima H, Kimura Y, Hirata K, Current status of the prognostic molecular biomarkers in breast cancer: A systematic review, Oncology Letters, doi: 10.3892/ol.2017.5609.3892/ol.2017.5609
Kanno S, Nosho K, Ishigami K, Yamamoto I, Koide H, Kurihara H, Mitsuhashi K, Shitani M, Motoya M, Sasaki S, Tanuma T, Maguchi H, Hasegawa T, Kimura Y, Takemasa I, Shinomura Y, Nakase H. MicroRNA-196b is an independent prognostic biomarker in patients with pancreatic cancer., Carcinogenesis., 2017
Ota S, Nishimura M, Murakami Y, Birukawa NK, Yoneda A, Nishita H, Fujita R, Sato Y, Minomi K, Kajiwara K, Miyazaki M, Uchiumi M, Mikuni S, Tamura Y, Mizuguchi T, Imamura M, Meguro M, Kimura Y, Hirata K, Niitsu Y., Involvement of Pancreatic Stellate Cells in Regeneration of Remnant Pancreas after Partial Pancreatectomy., PLoS One., 41616, 11(12), e0165747, 2016, doi: 10.1371/journal.pone.0165747
Ito T, Honma Y, Hijioka S, Kudo A, Fukutomi A, Nozaki A, Kimura Y, Motoi F, Isayama H, Komoto I, Hisamatsu S, Nakajima A, Shimatsu A., Phase II study of lanreotide autogel in Japanese patients with unresectable or metastatic well-differentiated neuroendocrine tumors., Invest New Drugs., 2017 May 3., 10.1007/s10637-017-0466-8.
Sato Y, Ohnuma H, Nobuoka T, Hirakawa M, Sagawa T, Fujikawa K, Takahashi Y, Shinya M, Katsuki S, Takahashi M, Maeda M, Okagawa Y, Naoki U, Kikuch S, Okamoto K, Miyamoto H, Shimada M, Takemasa I, Kato J, Takayama T, Conversion therapy for inoperable advanced gastric cancer patients by docetaxel, cisplatin, and S-1 (DCS) chemotherapy: a multi-institutional retrospective study., Gastric Cancer, 20, 3, 517-526, 2017
Kubo T, Kawano Y, Himuro N, Sugita S, Sato Y, Ishikawa K, Takada K, Murase K, Miyanishi K, Sato T, Takimoto R, Kobune M, Nobuoka T, Hirata K, Takayama T, Mori M, Hasegawa T, Kato J., BAK is a predictive and prognostic biomarker for the therapeutic effect of docetaxel treatment in patients with advanced gastric cancer., Gastric Cancer, 19, 3, 827-838, 2016
Shinya Chihara, Early induction of direct hemoperfusion with a polymyxin-B immobilized column is associated with amelioration of hemodynamic derangement and mortality in patients with septic shock, J Artif Organs, Epub ahead of print, 2016
Satoshi Kazuma, Yoshiki Masuda, Hiroomi Tatsumi, Kanako Takahashi, Shinichiro Yoshida, Maiko Honma, Hitoshi Imaizumi, Michiaki Yamakage, Almost Total Airway Obstruction Due to Unidentified Massive Hemoptysis under Extracorporeal Membrane Oxygenation, Int J Crit Care Emerg Med, 2, 1, 012, 2016
Morita R, Hirohashi Y, Torigoe T, Ito-Inoda , Takahashi A, Mariya T, Asanuma H, Tamura Y, Tsukahara T, Kanaseki T, Kubo T, Kutomi G, Mizuguchi T, Terui T, Ishitani K, Hashino S, Kondo T, Minagawa N, Takahashi N, Taketomi A, Todo S, Asaka M, Sato N, Olfactory Receptor Family 7 Subfamily C Member 1 Is a Novel Marker of Colon Cancer-Initiating Cells and Is a Potent Target of Immunotherapy., Clin Cancer Res, 41455. 22, 3298-309, 2016
Jinno H, Inokuchi M, Ito T, Kitamura K, Kutomi G, Sakai T, Kijima Y, Wada N, Ito Y, Mukai H, The Japanese Breast Cancer Society clinical practice guideline for surgical treatment of breast cancer, 2015 edition., Breast Cancer, May, 23, 367-77, 2016
Tanabe A, Tanikawa K, Tsunetomi M, Takai K, Ikeda H, Konno J, Torigoe T, Maeda H, Kutomi G, Okita K, Mori M, Sahara H., RNA helicase YTHDC2 promotes cancer metastasis via the enhancement of the efficiency by which HIF-1α mRNA is translated, Cancer Lett, 41452, 376, 34-42, 2016
Tanaka T, Kutomi G, Kajiwara T, Kukita K, Kochin V, Kanaseki T, Tsukahara T, Hirohashi Y, Torigoe T, Okamoto Y, Hirata K, Sato N, Tamura Y, Cancer-associated oxidoreductase ERO1-α drives the production of VEGF via oxidative protein folding and regulating the mRNA level, Br J Cancer, 41417, 114, 1227-34, 2016
Shima H, Kutomi G, Kyuno T, Satomi F, Uno S, Maeda H, Kameshima H, Omura T, Kimura Y, Mizuguchi T, Hirata K, Takemasa I., Flap revascularization in patients following immediate reconstruction using an autologous free dermal fat graft for breast cancer: a report of two cases., Surg Case Rep, 41609, 54, 2016
Shima H, Kutomi G, Satomi F, Maeda H, Hirohashi Y, Hasegawa T, Mori M, Torigoe T, Takemasa I, SOX2 and ALDH1 as Predictors of Operable Breast Cancer., Anticancer Res, Jun, 36, 2945-53, 2016
Maeda H, Kutomi G, Satomi F, Shima H, Mori M, Hirata K, Takemasa I, Clinicopathological characteristics of thyroid cancer misdiagnosed by fine needle aspiration., Exp Ther Med, Oct, 12, 2766-2772, 2016
Kutomi G, Mizuguchi T, Satomi F, Maeda H, Shima H, Kimura Y, Hirata K, Current status of the prognostic molecular biomarkers in breast cancer: A systematic review., Oncol Lett, Mar, 13, 1491-1498, 2017
Kajiwara T, Tanaka T, Kukita K, Kutomi G, Saito K, Okuya K, Takaya A, Kochin V, Kanaseki T, Tsukahara T, Hirohashi Y, Torigoe T, Hirata K, Sato N, Tamura Y., Hypoxia augments MHC class I antigen presentation via facilitation of ERO1-α-mediated oxidative folding in murine tumor cells., Eur J Immunol, Dec, 46, 2842-2851, 2016
Bunta N, Sawamoto K, Uemura S, Toyohara T, Mori Y, Kyan R, Miyata K, Irifune H, Harada K, Narimatsu E., How to manage Tension gastrothorax: A case report of tension gastrothorax with multiple trauma due to traumatic diaphragmatic rupture., International Journal of Emergency Medicine, 2017
Yamamoto I, Nosho K, Kanno S, Igarashi H, Kurihara H, Ishigami K, Ishiguro K, Mitsuhashi K, Maruyama R, Koide H, Okuda H, Hasegawa T, Sukawa Y, Okita K, Takemasa I, Yamamoto H, Shinomura Y, Nakase H., EZH2 expression is a prognostic biomarker in patients with colorectal cancer treated with anti-EGFR therapeutics., Oncotarget, 8, 11, 17810-8, 2017
Tanabe A, Tanikawa K, Tsunetomi M, Takai K, Ikeda H, Konno J, Torigoe T, Maeda H, Kutomi G, Okita K, Mori M, Sahara H., RNA helicase YTHDC2 promotes cancer metastasis via the enhancement of the efficiency by which HIF-1α mRNA is translated., Cancer Lett., 376, 1, 34-42, 2016
Kurihara H, Maruyama R, Ishiguro K, Kanno S, Yamamoto I, Ishigami K, Mitsuhashi K, Igarashi H, Ito M, Tanuma T, Sukawa Y, Okita K, Hasegawa T, Imai K, Yamamoto H, Shinomura Y, Nosho K., The relationship between EZH2 expression and microRNA-31 in colorectal cancer and the role in evolution of the serrated pathway., Oncotarget, 7, 11, 12704-17, 2016
Shima H, Kutomi G, Satomi F, Maeda H, Hirohashi Y, Hasegawa T, Mori M, Torigoe T, Takemasa I, SOX2 and ALDH1 as predictors of operable breast cancder, Anticancer Res., 36, 6, 2945-53, 2016
Shima H, Kutomi G, Kyuno T, Satomi F, Uno S, Maeda H, Kameshima H, Omura T, Kimura Y, Mizuguchi T, Hirata K, Takemasa I, Flap revascularization in patients following immediate reconstruction using an autologous free dermal fat graft for breast cancer: a report of two cases., Surg Case Rep., 2, 1, 54, 2016
Mizuguchi T, Mizuguchi T, Torigoe T, Satomi F, Shima H, Kutomi G, Ota S, Ishii M, Hayashi, H, Asakura S, Hirohashi Y, Meguro M, Kimura Y, Nishidate T, Okita K, Ishino M, Miyamoto A, Hatakenaka M, Sato N, Hirata K., Trials of vaccines for pancreatic ductal adenocarcinoma: Is there any hope of an improved prognosis?, Surg Today, 46, 2, 139-148, 2016
Kobayashi K, Sumikawa Y, Kikuchi Y, Kan Y, Kato J, Satomi F, Shima H, Kutomi, G, Yamashita T. Synchronous Paget disease of the breast and axilla., Synchronous Paget disease of the breast and axilla., J Am Acad Dermatol, 72, 1, e44-45, 2016
Kutomi G, Ohmura T, Satomi F, Maeda H, Shima H, Kameshima H, Okazaki M, Masuoka H, Sasaki K, Hirata K., A phase I study of combination therapy with nanoparticle albumin-bound paclitaxel and cyclophosphamide in patients with metastatic or recurrent breast cancer., Int J Clin Oncol, 20, 3, 474-479, 2015
Yasunori Matsumoto, Masayuki Kano, Yasunori Akutsu, Naoyuki Hanari, Isamu Hoshino, Kentaro Murakami, Akihiro Usui, Hiroshi Suito, Masahiko Takahashi, Ryota Otsuka, Hu Xin, Aki Komatsu, Keiko Iida, and Hisahiro Matsubara, Quantification of plasma exosome is a potential prognostic marker for esophageal squamous cell carcinoma., Oncology report, 36, 5, 2535-2543, 2016
Toyozumi T, Hoshino I, Takahashi M, Usui A, Akutsu Y, Hanari N, Murakami K, Kano M, Akanuma N, Suitoh H, Matsumoto Y, Sekino N, Komatsu A, Matsubara H., Fra-1 Regulates the Expression of HMGA1, Which is Associated with a Poor Prognosis in Human Esophageal Squamous Cell Carcinoma., Annals of surgical oncology, 2016
